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Abstract
Potrero Hill Health Center through the San Francisco Department of Public Health aims
to deliver health promotion, disease prevention, heath maintenance, counseling, and health
education of acute and chronic diseases. Hypertension is a common problem to both the health
center and to the general population, and Potrero Hill Health Center aims to understand and
develop a program that will aid in hypertension management at their local clinic. A supplemental
pharmacist service was implemented at Potrero Hill Health Center to help manage hypertensive
patients. Systolic and diastolic blood pressure levels were compared in patients receiving
pharmacist counseling versus those receiving physician services only. Preliminary findings
demonstrated that when compared to treatment as usual, those receiving supplemental
pharmacist services had better hypertension control with significant reductions in both systolic
and diastolic levels. Pharmacist counseling in community health clinics may have a beneficial
public health impact in controlling hypertension, thus reducing potential complications of
hypertension such as cardiovascular disease in low-income, minority populations.
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According to the Centers for Disease Control and Prevention, 70 million American adults
have hypertension, which translates to about 1 in every 3 adults. Among those, only half have
their high blood pressure under control (CDC, 2016). Individuals of low socioeconomic status
and of minority backgrounds are disproportionately affected by hypertension. Community
safety-net clinics are burdened by low resources and struggle to maintain adequate hypertension
control in low income and minority patients and reduce health disparities in cardiovascular
disease in the U.S.
Background
Data from the National Health and Nutrition Examination Surveys (NHANES) 19992014 showed that 29.0% of adults had hypertension in 2011-2014 and the prevalence increased
with age: 18–39, 7.3%; 40–59, 32.2%; and 60 and over, 64.9%, with a similar pattern between
genders (Carroll et al., 2015). It was also higher among non-Hispanic black (41.2%) than nonHispanic white (28.0%), non-Hispanic Asian (24.9%), or Hispanic (25.9%) adults. The
prevalence of controlled hypertension was 53.0% overall, and those aged 18-39 were less likely
to have controlled hypertension than those aged 60 and over. Between races, the prevalence of
control was higher among non-Hispanic white (55.7%) than non-Hispanic black (48.5%), nonHispanic Asian (43.5%), or Hispanic (47.4%) adults. Men and women had similar rates of
control at 29.0% and 30.0% respectively. Among men with hypertension, non-Hispanic white
(53.8%) adults had a higher prevalence of controlled hypertension compared with non-Hispanic
black (43.8%), non-Hispanic Asian (39.9%), and Hispanic (43.5%) adults. For women with
hypertension, the percentage of non-Hispanic white (59.1%) adults with controlled high blood
pressure was higher than that of non-Hispanic black (52.3%) and non-Hispanic Asian (46.8%)
adults (Carroll et al., 2015).
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Hypertension is a major cause of illness and disability and significantly increases the risk
for heart disease and stroke – two leading causes of death in the United States (CDC, 2016).
While heart disease and stroke are among the most preventable diseases, they are also the most
widespread and costly, accounting for hundreds of billions of dollars annually through healthcare
expenditures and lost productivity. Hypertension alone cost the nation $46 billion annually,
including the cost of health care services, medications to treat hypertension, and missed days of
work. Additionally, it is a primary or contributing cause of death of more than 360,000
Americans each year (CDC, 2016).
Lack of education and understanding may be a barrier to adequate hypertension control.
From 2011-2012, 82.7% of those with hypertension were aware that they had it, and 75.6%
reported currently taking prescribed medications to lower their blood pressure, while only 51.8%
had it under control (Burt et al., 2013). Taking antihypertensive medications was higher in
women (80.6%) than men (70.9%) and increased with age: 44.5% for those aged 18–39, 73.7%
for those 40–59, and 82.2% for those 60 and over. Non-Hispanic Asian adults were less likely to
report taking antihypertensive medication (65.2%) than were non-Hispanic black (77.4%) and
non-Hispanic white (76.7%) adults (Burt et al., 2013). This highlights that prescribing
medication alone is not sufficient in controlling hypertension. While the control rate has
increased from 29% in 1999 to an upwards of 54%, there is still room for improvement to meet
the Healthy People 2020 goal of 61.2% (Carroll et al., 2015).
The American Heart Association has several recommendations on how to prevent and
treat hypertension. Primary prevention begins with understanding one’s risk factors, such as race,
age, family history, comorbidities, and unhealthy habits. Secondary prevention involves having
blood pressure checked and accurately diagnosed by a healthcare professional. Lifestyle changes
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to adopt are part of both primary and tertiary prevention, including eating a healthier diet and
reducing salt intake, engaging in regular physical activity, maintaining a healthy weight,
managing stress, and avoiding or limiting tobacco smoke and alcohol. In addition, tertiary
prevention includes compliance with medication if taken (American Heart Association, 2016).
Pharmacists Role in Hypertension Control
There has been limited but promising results with use of a pharmacist in aiding in blood
pressure control and management amongst hypertensive patients in primary care settings.
Whether a pharmacist was utilized in collaboration with a physician or more independently, the
literature supports pharmacist roles as a significant factor in the care of hypertensive adults.
Through pharmacist-lead clinics that focus on blood pressure, patients can receive individualized
care towards their hypertension management, including proper titration of medications and closer
monitoring of adherence to their medications, diets, and lifestyle habits. In a study conducted by
Hunt et al. (2008), subjects who received the intervention of pharmacist-lead blood pressure
consults achieved significantly lower systolic (Δ = 6 mmHg, p = 0.007) and diastolic
(Δ = 3 mmHg, p = 0.002) blood pressures compared to control subjects (137/75 mmHg vs.
143/78 mmHg). In addition, 62% of those receiving the intervention achieved target blood
pressure compared to 44% of those who did not (p = 0.003). The odds of achieving blood
pressure target in the intervention group were 2.08 times higher than the control group. These
results have been consistent in many studies that include pharmacists to manage blood pressure
in primary care settings. In another study conducted by Carter et al. (2015), blood pressure
control rate monitored after discontinuation of a pharmacist-lead program in a Veterans Health
Administration setting. After 6 months, blood pressure remained to be controlled at a rate above
50%, but did not sustain over longer periods of time.
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Based on research evidence, a “Blood Pressure Clinic” was implemented at an urban
primary care community clinic to examine the effectiveness of a pharmacist lead hypertension
management program. This paper reports on a preliminary evaluation of the “Blood Pressure
Clinic” that aimed to increase blood pressure control in a predominately low income minority
population with hypertension.
Potrero Hill Health Center: An Urban Safety Net Clinic
Potrero Hill Health Center (PHHC) is a primary care clinic located in San Francisco,
California, in affiliation with the San Francisco Department of Public Health (SFDPH) and San
Francisco General Hospital. It is among 12 clinics that provide primary care for adults, and
includes services for pharmacy, nutrition, and mental, dental, and prenatal health. The overall
mission of the SFDPH is to protect and promote the health of all San Franciscans, and through
the help of clinics such as PHHC, patients can receive family-centered, comprehensive, and
team-based care that is focused on quality and safety. The clinic is focused on delivering health
promotion, disease prevention, heath maintenance, counseling, health education, and diagnosis
and treatment of acute and chronic diseases. The target population of PHHC is minority adults of
low-socioeconomic class. Amongst ethic backgrounds, 33.01% are Hispanic/Latino, 23.77% are
Black/African American, 18.46% are White/Caucasian, 13.32% are Asian, 1.99% are Native
Hawaiian, and the remaining 9.45% Other. Hypertension and diabetes are the most common
morbidities seen at the clinic, with a prevalence of 35.17% and 15.99% respectively. The current
blood pressure control rate is 65.8% among hypertensive adults at the clinic.
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Evaluation of the Blood Pressure Clinic
Purpose
The purpose of the project was to examine whether utilizing a pharmacist-lead blood
pressure clinic (BP Clinic) involving medication titration and health education would improve
blood pressure control in hypertensive patients at the Potrero Hill Health Center.
Hypothesis
Individuals who attend at least one pharmacist-lead blood pressure session will have
better blood pressure control than those who are provided usual care in a one-year period.
Methods and Criteria
Hypertensive patients at Potrero Hill Health Center in San Francisco, CA were observed over
the course of a year, from July 2015-September 2016. Blood pressure readings were collected
and analyzed at 3, 6, and 12-month intervals. Hypertensive patients were defined as those who
had hypertension listed on their problem list on their electronic medical record (EMR). Blood
pressure control was defined according to the Joint National Committee 8 (JNC-8) guidelines as:
•

Age < 60 years without diabetes mellitus, chronic kidney disease, or other major
comorbidities: < 140/90mmHg

•

Age 60 years or older without diabetes mellitus, chronic kidney disease, or other major
comorbidities: < 150/90mmHg

•

Age 18 years or older with diabetes mellitus, chronic kidney disease, or both:
< 140/90mmHg

Individuals who met the JNC-8 criteria were considered at goal. Those whose systolic or
diastolic were higher than the JNC-8 criteria were considered above goal.
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Starting July 2015, hypertensive patients at the clinic who had blood pressure levels
above goal were referred to the pharmacist-lead blood pressure session held at the clinic once a
week. Referrals were made by their primary care providers at regular appointments or through
telephone outreach encounters. Patients in the usual care arm were not referred by primary care
provider, or did not attend a BP clinic session after a referral. Demographic data including age,
race/ethnicity, and diabetes and chronic kidney disease status were collected on those who
attended BP Clinic and those who did not.
BP Clinic was held once a week at PHHC on Fridays, with an average of 3-4 sessions per
month. It was lead by a single pharmacist who had access to patients’ EMR and knowledge of
their clinical history. Each session included taking a blood pressure reading, follow-up with
medication adherence, medication titration and education on recommended diet and exercise
regimens to improve blood pressure. Outreach calls were made using the hypertension registry
collect from the health database i2i, which was filtered to patients at PHHC, patients with
hypertension on their problem list according to EMR, and patients who had at least one blood
pressure reading above goal defined as SBP >/= 140 or DBP >/= 90 from January 1, 2015 –
September 31, 2016. A total of 120 patients were in the BP clinic cohort and 296 in the usual
care cohort. Among the BP clinic cohort, baseline blood pressure was determined by the most
recent reading prior to their first BP Clinic session that was above goal. Among the usual care
cohort, baseline blood pressure was determined by a reading above goal on or before September
2016. Using the date of the baseline blood pressure, 3, 6, and 12-month intervals were taken
from there. Due to the observational method of collection, it was likely that patients did not have
a reading at a certain time interval. In that case patients were not excluded from the study; rather,
there was just one less data point to utilize for that time interval. At the end of the one-year
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study, any patient (usual care group) who did not have a 12-month blood pressure listed was
substituted with the most recent reading available within the study time frame. For both cohorts,
a single blood pressure reading was utilized for each time interval. If multiple readings existed,
the last one was used.
The following outcomes were measured: primary—comparing the percentage of patients
with blood pressure control as defined by the JNC-8 guidelines between those who attended BP
Clinic and those who did not after 12 months; secondary—comparing demographic differences
observed between the two cohorts.
Statistical Analyses
Two independent sample t-tests were used to test whether the average difference between
the two cohorts were significant or due to random chance. Excel software and Google calculator
were used to compute data.
Results
Patients who attended at least one session of BP Clinic had a greater percentage of blood
pressure control as defined by the JNC-8 Guidelines at the end of one year (71.67% vs. 53.04%,
see Table 1). Overall average systolic and diastolic blood pressure in both cohorts were
considered at goal, or below 140 and 90, at the end of one year. However, when looking at
individual cases, average systolic blood pressure in the BP Clinic cohort was 134.9 mmHg
compared to 139.1 mmHg in the usual care cohort, and the difference was significant at the alpha
= 0.05 level, df = 414, t = -1.649 (t = -2.027, p = 0.021651). Average diastolic blood pressure
was 78.0 mmHg in the BP clinic cohort compared to 84.6 mmHg in the usual care cohort, and
was significant at the alpha = 0.05 level, df = 414, t = -1.649, (t = -5.540, p < 0.00001). Average
change in systolic and diastolic blood pressure was greater among the BP clinic cohort compared
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to usual care (SBP Δ19.43mmHg vs. 16.45mmHg; DBP Δ9.23 vs. 8.50) (See Figure 1-4). In
both cohorts, African Americans were the most prevalent. Asian was the second most prevalent
in the BP Clinic cohort, while White was second in the usual care cohort. Hispanic/Latino was
third most prevalent for both cohorts. There were also a larger percentage of patients who had
diabetes or chronic kidney disease among those who attended BP Clinic compared to usual care
(49.17% vs. 35.47%).

Table 1: Blood Pressure Control and Demographics
BP CONTROL AT 1 YEAR
Yes
No

BP Clinic %
71.67
28.33

BLACK/AFRICAN AMERICAN BP CONTROL AT 1 YEAR
BP Clinic %
Yes
61.36
No
38.64

Non-BP Clinic %
53.04
46.96

Non-BP Clinic %
48.21
51.79

RACE/ETHNICITY
Black/African American
White
Hispanic/Latino
Asian
Native Hawaiian/ Other Pacific
Islander
Other/Refused

BP Clinic %
36.67
10.0
15.83
19.17
2.50

Non-BP Clinic %
37.84
16.55
16.22
15.20
3.38

15.83

10.81

BP Clinic
59

Non-BP Clinic
105

61

191

120
49.17%

296
35.47%

DISEASE STATUS
YES Diabetes/
Chronic Kidney Disease
NO Diabetes/
Chronic Kidney Disease
Total
Percent Yes
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Figure 1: BP Clinic
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Figure 2: Usual Care
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Figure 3: BP Clinic vs. Usual Care Line
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Figure 4: BP Clinic vs. Usual Care Column
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Limitations
This evaluation had many strengths including no additional cost to perform the study and
use of the same pharmacist, which promoted consistency. However, several limitations also
existed. Patient attendance could not be predicted or controlled, which resulted in data gaps at
certain time periods. Additionally, the method of data collection could have been influenced by
behavioral factors. Blood pressure measurements are sensitive and change according to posture,
exercise, sleep, stress, mental health, caffeine, and smoking. Utilizing a single event reading on
does not necessarily indicate the patient average blood pressure control. Recommended
guidelines to accurately diagnose hypertension include averaging 2-3 readings after a patient has
been sitting quietly for five minutes. In this study we could not control for environmental factors
and used the last single blood pressure reading rather than an average. Lastly, missing data was
not replaced or omitted, so each time interval represented a different cohort.
An important factor to consider is that there were a higher percentage of diabetic/chronic
kidney disease patients in the BP Clinic cohort. Patients who have symptomatic comorbidities
such as diabetes and chronic kidney disease may tend to be more involved with their personal
health, compared to those with a sole diagnosis of hypertension therefore are more likely to seek
medical care. Behavioral modifications and treatments that patients with diabetes/chronic kidney
disease are already utilizing can also have a positive effect on their blood pressure.
Public Health Significance
Interventions that include pharmacists to improve blood pressure control in hypertensive
adults have shown promising results. In many primary care settings physicians have limited faceto-face time with patients to discuss comprehensive blood pressure management.
Utilizing ancillary clinic staff such as clinical pharmacists to titrate medications and reinforce
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medication adherence and lifestyle changes should be used as a best practice method for
hypertension management in order to meet the Healthy People 2020 goal of 61.2%. Improving
blood pressure control also closes the gap in health disparities by reducing cardiovascular disease
and increases cost savings of the nation.
Conclusion
Hypertension management is imperative because it is common in the population,
especially among low-income, underserved populations, which are frequently the target
population when we address any public health issue. The potential consequences of uncontrolled
or untreated hypertension not only affect the people who have it, but also the people who are
around them such as friends and family. Further attention about education is imperative not only
to the disease itself, but for the general health of our population. Promoting lifestyle changes
such as eating a healthy diet and engaging in regular physical activity is applicable to overall
improved health, and has shown to be a positive effect on mental health, women and children’s
health, improved performance at school, and so forth. It is a disease that everyone should be
aware of, and one that everyone should understand how to prevent or treat.
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Results

Instruments

Subjects

Design

Subjects in the intervention arm had
significantly lower systolic and
diastolic blood pressures compared
to control, 62% of intervention
subjects achieved target blood
pressure compared to 44% of
control subjects. Minimal
differences between groups in
hypertension-related knowledge,
medication adherence, quality of
life, or satisfaction.

Baseline blood pressure was compared to
1st follow-up and 2nd follow-up
measurements, however, length of time
between appointments not specified

Purpose
A total of 463
subjects
(n = 233
control,
n = 230
intervention)

Intervention arm had significantly
lower systolic and diastolic blood
pressures compared to the control
arm, and also had better mean score
on the quality of life questionnaire.

Limitations
Weaknesses
Single-blind study, 16% response rate,
combination drug therapy in the
intervention arm

20 to 75 years
old, 102 total,
(n = 48
control, n = 54
intervention)

Unable to generalize to population outside
the VA; patients were largely male,
Midwestern, and Caucasian; high pvalues

Singleblind,
RCT

RCT

Short Form-36
quality of life
questionnaire,
pictograms,
interviews

Significant decrease in blood
pressure among those who
continued the intervention after 6
months. Data for 12, 18, and 24month intervals were not
statistically significant to conclude
(p>0.1)

Mailed
invitations, selfreported
questionnaires,
appropriate sized
cuffs and
standard mercury
sphygmomanom
eter

RCT

10-item Pfeiffer
Short Portable
Mental Status
Questionnaire,
automated BP
machine

Iowa Veterans
Administration
, 123 total
participated
(62 stop
intervention,
61 continue
intervention)

Pharmacist
practitioners
vs. usual care
in
hypertension
management,
communitybased setting
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Author
Date
Hunt et
al.
2008

Wal et al.
2013

Carter et
al.
2015

Pharmaceutica
l care (patient
education,
prescription
assistance, and
the life style
modifications)
vs. none
Examine blood
pressure
control after
discontinuatio
n of
pharmacistmanaged
intervention

RCT

Age 18 and
older, n = 75
intervention
arm, n = 91
control

More patients in the intervention arm
were at blood pressure goal at 6 and
9 months compared to usual care.
Reduction in average BP was also
greater in the intervention at 6
months, but was not statistically
significant at 9 months

Only generalizable to similar settings,
subjects involved were not masked

Not generalizable due to single
university-based general internal
medicine practice; patient had to be able
to speak, read, and write English;
patients received small payments for
each clinic visit; participation bias
because those who were in the
intervention knew that they were and
those in usual care did not
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Blood pressure not controlled (not
statistically significant), however,
reduction in mean blood pressure
was greater in the intervention arm
than control

Low response rate, chose to participate

Small sample, randomization not
guaranteed, even or odd last digit SSN
was entered by a person, who could
easily figure out the pattern

Publication bias, small studies showing
weak or no effect may not have been
published

More than double the percentage of
those in the intervention arm
achieved blood pressure control
compared to control, with greater
decline in diastolic and systolic blood
pressures
Individuals vary widely in their
preferences for possible outcomes,
marked disagreement with results
from decision analysis

Compared with usual care,
pharmacist interventions showed
greater reduction in systolic and
diastolic blood pressure. The effect
tended to be larger if the intervention
was led by the pharmacist and was
done at least monthly.
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Hirsh et
al.
2014

Pharmacist
practitioners
vs. usual care
in

Clinical
collaborative
practice protocol,
manual wallmounted
sphygmomanom
eter

625 total
subjects (n =
401
intervention, n
= 224 control)

Carter et
al.
2015

Survey to score
clinical
pharmacy
services

Physician/phar
macist
collaborative
model primary
care medical
offices across
15 states

n = 49
intervention, n =
46 control

Prospec
tive,
clusterrandomi
zed trial

Pharmacist
interventions
(alone or in
collaboration
with other
healthcare
professionals)
Singleblind,
RCT

Metaanalysis
of RCTs

Santschi
et al.
2014

Physician and
pharmacist
teamwork
approach

Interviews

MEDLINE,
EMBASE,
CINAHL, and
CENTRAL
databases

Bodgen
et al.
1998

Observa
tional
study

52 patients
responded to
invitation (out
of 100), which
were chosen
randomly

39 RCTs
representing
14,224
patients, trials
were published
between 1973
and 2013 in
peer-reviewed
journals
Interviews,
JNC-5
guidelines

Montgom
ery et al.
2001

Compare
patient
preferences of
treatment to
recommended
guidelines

Appel
2003

Jolles et
al.
2013

Heymann
et al.
2012

Medications
and/or lifestyle

Lifestyle
modifications
to control
blood pressure

Assess
knowledge and
beliefs of
hypertension

Explore beliefs
and
perceptions of
hypertension,
gain
understanding
of barriers

Review
article

Review
article

Qualitat
ive
study

Qualitat
ive
study

Semi structured
interviews with
topic guide, 3060 minutes

Focus groups

Age 18 older,
26 total
patients

10 focus
groups, 86
total people

Participants saw hypertension has a
risk factor for MI or stroke, rather
than a disease. Viewed as a binary
risk process (have it or not) rather
than a continuous, degenerative
process. Diabetic patients more likely
to accept hypertension as a chronic
illness with minor impact on their
routine, and less important than their
diabetes. Stress was overestimated as
the most important causative factor.
Only half of patients were able to
recall optimal or target blood
pressure.
The majority could recall
consequences of hypertension.
Patients aware of the impact of
lifestyle modifications, however,
failed to translate this into
implementation. A lack of a routine
for medication use was the most
frequently reported barrier to proper
BP control. Physicians too busy to
answer questions, 69% received
more information from another
healthcare professional.
Increasing physical activity,
maintaining healthy body weight,
moderate alcohol intake, diet high in
fruits, and vegetables, potassium and
low in fat and salt
Consider white coat hypertension
(increased blood pressure when a
clinician is present)
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Collier
and
Landram
2012
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Participants were agreeable to
participate, may have high health
awareness, doesn’t highlight the extent
of non-adherence of hypertension

Small sample, participants agreed to
participate (participation bias)
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Appendix B. Competencies & Goals & Objectives
Competencies Achieved
Throughout this fieldwork I completed learning objectives that contributed to my
achievement in the University of San Francisco’s Master of Public Health competencies,
including:
1. Assessing, monitoring, and reviewing the health status of populations and their related
determinants of health and illness
2. Demonstrating the ability to utilize the proper statistical and epidemiologic tools to assess
community needs and program outcomes
3. Identifying and prioritizing key dimensions of a public health problem by critically assessing
the public health literature
4. Demonstrating leadership abilities and effectively communicating with partners as a
collaborator of evidence-based public health projects
Goals and Objectives
Goal 1: Identify and Explore a Public Health Problem at Potrero Hill Health Center (PHHC)
Objectives
Activities
Timeframe
Who is
Tracking Measures
Responsible
Identify which
Ask providers and
Mar 22 - Apr 12
Pandora and
Provided list of
morbidities are the staff about most
appropriate staff
most common
most prevalent at
common problems
problems
PHHC
in the population
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Understand why
the problem exists,
intervention and
best-practices to
combat the
problem

Conduct literature
review

Mar 22 - Sep 22

Pandora

22

Read lit reviews

Goal 2: Understand the Importance of Engaging and Maintaining Communication with Partners
Objectives
Activities
Timeframe
Who is
Tracking Measures
Responsible
Have at least one
Communicate onMar 22 - Nov 3
Pandora and
Notes taken from
30-minute meeting site days with
Preceptor
meeting
with preceptor
preceptor to set
once a week while meeting up
on site
Communicate via
Email questions
Mar 22 - Nov 3
Pandora and
Email exchanges
email as needed
concerns when
Preceptor
preceptor or
student unavailable
for meetings
Goal 3: Understand Different Data Analyses Techniques and Appropriately Utilize Towards a Quality Improvement
Project
Objectives
Activities
Timeframe
Who is
Tracking Measures
Responsible
Explore the
Conduct literature
Mar 22- Nov 3
Pandora
Read lit reviews
different types of
review
studies and
methods used
Collect and
Create
Mar 22- Nov 3
Pandora
Spreadsheets,
organize data
spreadsheets,
tables, and graphs
tables, and graphs
made
Conduct analyses
Identify and
Jul 6 - Nov 3
Pandora
Results and pfor conclusion
perform test
values
Goal 4: Increase Participation Rates of Current Programs at PHHC
Objectives
Activities
Timeframe
Who is
Responsible
Assess current
Ask providers and
Mar 22 - Nov 3
Pandora and
participation rates
staff for data on
appropriate staff
and outreach
participation rate
strategies of
programs
Determine
Ask providers and
Mar 22 - Sept 22
Pandora and
preferred method
front desk to
appropriate staff
of communication
include
among patients
communication
preferences during
visit
Broaden scope of
Create new flyers
Mar 22 - Sep 19
Pandora
outreach
for existing
programs

Tracking
Measures
List of rates

Preferred method
listed in medical
record chart

Flyers made

